The Latest Analyst Ratings For Molina Healthcare
Portfolio Pulse from Benzinga Insights
Analyst ratings for Molina Healthcare (NYSE:MOH) show a mix of opinions, with recent updates indicating a positive trend in price targets. The average 12-month price target has increased to $374.00, with a high of $392.00 and a low of $350.00. Analysts from UBS, Cantor Fitzgerald, JP Morgan, and Stephens & Co. have provided recent evaluations, with UBS and JP Morgan raising their price targets. Molina Healthcare operates Medicaid-related health plans and has shown a revenue growth of 7.83% as of September 30, 2023, with a strong net margin of 2.87% and ROE of 6.53%, but carries a higher debt-to-equity ratio of 0.61.
December 21, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Molina Healthcare's average 12-month price target has been raised, indicating analyst optimism. The company's strong revenue growth and financial performance metrics are positive, but its higher debt-to-equity ratio may be a concern.
The increase in the average price target for MOH suggests that analysts are optimistic about the company's future performance. The positive revenue growth and financial metrics like net margin and ROE support this view. However, the higher debt-to-equity ratio could be a concern for some investors, potentially moderating the positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100